Green, D., Twardowski, P., Wei, R., and Rademaker, A.W.: Fatal pulmonary embolism in spinal cord injury. Chest 105 (3): 853-855, 1994.
Gately, S., Twardowski, P., Stack, S., Patrick, M., Boggio, L., Cundiff, D., Schnaper, W., Madison, L.,Volpert, O., Bouck, N., Enfhild, J., Kwaan, H., and Soff, G.: Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res. 56: 4887-4890, 1996.
Green D., Wong, C.A., and Twardowski, P.: Efficacy of hemostatic agents in improving surgical hemostasis. Transfusion Rev. 10 (3): 171-182, 1996.
Twardowski, P., and Gradishar, W.: Clinical trials of antiangiogenic agents. Current Opin. Oncol. 9: 584-589,1997.
Gately, S., Twardowski, P., Soff, G., et al.: The mechanism of cancer-mediated conversion of
plasminogen to the angiogenesis inhibitor angiostatin. Proc. Natl. Acad. Sci. USA 94: 10868-10872, 1997.
Yen Y, Doroshow JH, Chow W, Leong L, Margolin K, Morgan R, Raschko J, Shibata S, Somlo G, Twardowski P, Frankel P, Longmate J, Synold T, and Newman E. Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea (HU) in combination with gemcitabine (Gem): A California Cancer Consortium Trial. Cancer Chemother. Pharmacol. 50: 353-359, 2002.
Openshaw, H., Beamon, K., Synold, T., Longmate, J., Slatkin, N.E., Chow, W., Doroshow, J.H., Forman, S., Leong, L., Lim, D., Morgan, R., Margolin, K., Shibata, S., Twardowski, P., and Somlo, G.: Neurophysiological study of peripheral neuropathy after high dose paclitaxel: Lack of neuroprotective effect of amifostine. Clin. Cancer Res. 10: 461-467, 2004.
Somlo, G., Frankel, P., Chow, W., Leong, L., Margolin, K., Morgan, Jr., R., Shibata, S., Chu, P., Forman, S., Twardowski, P., Weitzel, J., Alvarnas, J., Kogut, N., Schriber, J., Fermin, E., Damon, L. and Doroshow, J.H. Prognostic indicators and survival in 120 patients with stage IIIB inflammatory breast carcinoma following dose-intense chemotherapy. J. Clin. Oncol. 22: 1839-1848, 2004.
Morgan, R.J., Jr., Doroshow, J.H., Synold, T., Lim, D., Shibata, S., Margolin, K., Schwarz, R., Leong, L., Somlo, G., Twardowski, P., Yen, Y., Chow, W., Lin, P., Paz, B., Chu, D., Frankel, P., and Stalter, S.: Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies confined to the peritoneal cavity: Dose-limiting toxicity and pharmacokinetics. Clin. Cancer Res. 9:5896-5901 (2003).
Chow, W.A., Synold, T.W., Tetef, M.L., Longmate, J., Frankel, P., Lawrence, J., Al-Kadhimi, Z., Leong, L., Lim, D., Margolin, K., Morgan, R.J., Jr., Raschko, J., Shibata, S., Somlo, G., Twardowski, P., Yen, Y., Doroshow, J.H.: Feasibility study of concurrent infusional dexrazoxane and dose-intensive doxorubicin administered over 96 hours for the treatment of advanced malignancies. Cancer Chemother. Pharmacol. 54: 241-248, 2004.
Liu, G., Gandara, D.R., Lara, P.N. Jr., Raghavan, D., Doroshow J.H., Twardowski, P., Kantoff, P., Oh, W., Kim, K., Wilding, G.: A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer. Clin Cancer Res. 10:924-928, 2004.
Lara, P.N. Jr., Chee, K.G., Longmate, J., Ruel, C., Meyers, F.J., Gray, C.R., Edwards, R.G., Gumerlock, P.H., Twardowski, P., Doroshow, J.H., Gandara, D.R.: Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial. Cancer. 100:2125-2131, 2004.
Lara, P.N. Jr., Twardowski, P.: Angiogenesis-targeted therapies in prostate cancer. Clin Prostate Cancer. 3:165-173, 2004.
Lara, P.N. Jr., Law, L.Y., Wright, J.J., Frankel, P., Twardowski, P., Lenz, H.J., Lau, D.H., Kawaguchi, T., Gumerlock, P.H., Doroshow, J.H., Gandara, D.R.: Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a Phase I California Consortium Trial. Anticancer Drugs. 16:317-321, 2005.
Margolin, K.A., Doroshow, J.H., Frankel, P., Chow, W., Leong, L.A., Lim, D., McNamara, M., Morgan, R.J., Shibata, S., Somlo, G., Twardowski, P., Yen, Y., Kogut, N., Schriber, J., Alvaranas, J., and Stalter, S.: Taxol-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer: Effective salvage therapy for poor-risk patients in first relapse. Submitted for publication.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/06.
